Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluviral Efficacy in Healthy Adults
NCT00216242Phase 3Unknown
- Sponsor
- ID Biomedical Corporation
- Start
- Sep 2005
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing Fluviral with Placebo (2 arms). Primary endpoint: Incidence of culture confirmed influenza-like illness due to virus strains matching the vaccine. Status: unknown.
02
Drugs
influenza a (h1n1) 2009 pandemic monovalent vaccine (without adjuvant)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00216242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216242.